Back to results
US 2019/0161514 A1Published application
Azasteroids for treatment of tuberculosis
AssigneeThe Research Foundation for The State University of New York
InventorsNicole Sampson, Xinxin Yang, Tianao Yuan
Life of this patent
Estimating the term…
Abstract
The present invention provides a compound having the structure: for use in combination with an anti-tuberculosis drug for treating a subject infected with M. tuberculosis.
Claims24
A compound having the structure:
- wherein
- α is absent or present and when present is a bond,
- wherein when R3 and R4 combine to form a cycloalkyl group, then α is absent;
- X is —NH—, —NH—NH—, —NH—C(O)—, —NH—C(S)—, —NH—NHC(O)— or —NH—NHC(S)—;
- R1 is —H, alkyl, alkenyl, alkynyl, aryl, heteroaryl, C(O)-alkyl, C(O)-haloalkyl, C(O)-cycloalkyl, C(O)-alkenyl, C(O)-alkynyl, C(O)-aryl, C(O)-heteroaryl, CO2-alkyl, CO2-alkenyl, CO2-alkynyl, CO2-aryl, CO2-heteroaryl, cycloalkyl, alkyl-OH, alkyl-NH2, SO2-alkyl, SO2-haloalkyl, SO2-cycloalkyl, SO2-alkenyl, SO2-alkynyl, SO2-aryl, SO2-heteroaryl or L-(anti-tuberculosis drug);
- R2 is H, halo, alkyl, alkenyl, alkynyl, aryl, heteroaryl, CO2-alkyl, CO2-alkenyl, CO2-alkynyl, CO2-aryl, CO2-heteroaryl, cycloalkyl, alkyl-OH, alkyl-NH2 or alkyl-N(alkyl)2;
- R3 is —H, halo, alkyl, alkenyl, alkynyl, aryl, heteroaryl, CO2-alkyl, CO2-alkenyl, CO2-alkynyl, CO2-aryl, CO2-heteroaryl, cycloalkyl, alkyl-OH, alkyl-NH2 or alkyl-N(alkyl)2, and
- R4 is —H, halo, alkyl, alkenyl, alkynyl, aryl, heteroaryl, CO2-alkyl, CO2-alkenyl, CO2-alkynyl, CO2-aryl, CO2-heteroaryl, cycloalkyl, alkyl-OH, alkyl-NH2, or alkyl-N(alkyl)2, or
- R3 and R4 combine to form a cycloalkyl group;
- R5 is a substituted aryl, substituted heteroaryl, alkylaryl or L-(anti-tuberculosis drug),
- wherein L is a chemical linker comprising a functional group capable of forming a bond with an anti-tuberculosis drug;
- wherein when α is absent, X is NH, and R1, R2, R3 and R4 are each H, then R5 is other than 2-(tert-butyl)-5-(trifluoromethyl)phenyl, 2,5-di-tert-butylphenyl, 4-morpholindphenyl or 2-benzoylphenyl,
- or a salt or ester thereof.
10 more elements
(canceled)
(canceled)
20-21. (canceled)
23-28. (canceled)
A method of treating a subject infected with M. tuberculosis comprising administering to the subject an amount of the compound having the structure:
- wherein
- α is absent or present and when present is a bond,
- wherein when R3 and R4 combine to form a cycloalkyl group, then α is absent;
- X is —NH—, —NH—NH—, —NH—C(O)—, —NH—C(S)—, —NH—NHC(O)— or —NH—NHC(S)—;
- R1 is —H, alkyl, alkenyl, alkynyl, aryl, heteroaryl, C(O)-alkyl, C(O)-haloalkyl, C(O)-cycloalkyl, C(O)-alkenyl, C(O)-alkynyl, C(O)-aryl, C(O)-heteroaryl, CO2-alkyl, CO2-alkenyl, CO2-alkynyl, CO2-aryl, CO2-heteroaryl, cycloalkyl, alkyl-OH, alkyl-NH2, SO2-alkyl, SO2-haloalkyl, SO2-cycloalkyl, SO2-alkenyl, SO2-alkynyl, SO2-aryl, SO2-heteroaryl or L-(anti-tuberculosis drug);
- R2 is H, halo, alkyl, alkenyl, alkynyl, aryl, heteroaryl, CO2-alkyl, CO2-alkenyl, CO2-alkynyl, CO2-aryl, CO2-heteroaryl, cycloalkyl, alkyl-OH, alkyl-NH2 or alkyl-N(alkyl)2;
- R3 is —H, halo, alkyl, alkenyl, alkynyl, aryl, heteroaryl, CO2-alkyl, CO2-alkenyl, CO2-alkynyl, CO2-aryl, CO2-heteroaryl, cycloalkyl, alkyl-OH, alkyl-NH2 or alkyl-N(alkyl)2, and
- R4 is —H, halo, alkyl, alkenyl, alkynyl, aryl, heteroaryl, CO2-alkyl, CO2-alkenyl, CO2-alkynyl, CO2-aryl, CO2-heteroaryl, cycloalkyl, alkyl-OH, alkyl-NH2, or alkyl-N(alkyl)2, or
- R3 and R4 combine to form a cycloalkyl group;
- R5 is substituted aryl, substituted heteroaryl or alkylaryl,
- wherein when α is absent, X is NH, and R1, R2, R3 and R4 are each H, then R5 is other than 3-tert-butylphenyl, 4-morpholinophenyl, 2-benzoylphenyl or 2,5-trifluoromethylphenyl,
- when α is absent, X is NH, R1 is H or Boc, and R2, R3 and R4 are each H, then R5 is other than 2-trifluoromethoxy-4-halophenyl, 6-(5-fluoro-indol-1-yl)-2-(trifluoromethoxy)pyridin-3-yl or 2-trifluoromethoxy-3-trifluoromethylphenyl, and
- when α is absent, X is —NH—C(S)—, and R1, R2, R3 and R4 are each H, then R5 is other than 2-ethylpyridin-4-yl,
- or a salt or ester thereof, in combination with an anti-tuberculosis drug, so as to thereby treat the subject.
11 more elements
30-39. (canceled)
Dependencies are inferred from the claim text.